Cargando…

Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04

BACKGROUND: Hyperlipidaemia is the major risk factor contributing to the development and progression of atherosclerosis, fatty liver and cerebrovascular disease. Pleurotus eryngii (P. eryngii) is rich in biologically active components, especially polysaccharides that exhibit various biological activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Li, Juan, Wang, Jing, Song, Xingling, Zhang, Jianjun, Wu, Shang, Hu, Chunlong, Gong, Zhiyuan, Jia, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557422/
https://www.ncbi.nlm.nih.gov/pubmed/28806986
http://dx.doi.org/10.1186/s12906-017-1892-z
_version_ 1783257199994208256
author Zhang, Chen
Li, Juan
Wang, Jing
Song, Xingling
Zhang, Jianjun
Wu, Shang
Hu, Chunlong
Gong, Zhiyuan
Jia, Le
author_facet Zhang, Chen
Li, Juan
Wang, Jing
Song, Xingling
Zhang, Jianjun
Wu, Shang
Hu, Chunlong
Gong, Zhiyuan
Jia, Le
author_sort Zhang, Chen
collection PubMed
description BACKGROUND: Hyperlipidaemia is the major risk factor contributing to the development and progression of atherosclerosis, fatty liver and cerebrovascular disease. Pleurotus eryngii (P. eryngii) is rich in biologically active components, especially polysaccharides that exhibit various biological activities, including reducing blood lipids. In the present study, three novel polysaccharide types, including exopolysaccharides (EPS), enzymatic EPS (EEPS) and acidic EPS (AEPS) were isolated, and the hypolipidaemic and hepatoprotective effects were investigated to better understand possible hypolipidaemic mechanisms and their hepatoprotective effects. METHODS: The EPS was hydrolysed by snailase (dissolved in 1% acetic acid, pH = 6) and H(2)SO(4) (1 M) to obtain EEPS and AEPS, respectively. The in vitro antioxidant activities were measured by investigating the reducing power and the scavenging effects on radicals of hydroxyl, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and superoxide anion. The hyperlipidaemic mice were induced by perfusing a high-fat emulsion. In addition to the hepatic histopathology, the following biochemical analyses were performed to investigate the antioxidative effects, including the activities of alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT). Triacylglycerol (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA) and lipid peroxidation (LPO) levels were also measured in serum and liver homogenate. RESULTS: Supplementation of EPS, EEPS and AEPS could significantly improve blood lipid levels (TC, TG, HDL-C, and LDL-C), hepatic lipid levels (TC and TG), hepatic enzyme activities (ALP, ALT, and AST) and antioxidant status (GSH-Px, SOD, T-AOC, MDA, and LPO). In addition, histopathological observations indicated that these polysaccharides had potential effects in attenuating hepatocyte damage. CONCLUSION: These results demonstrated that both EPS and its hydrolysates EEPS and AEPS might effectively reduce serum lipid levels and protect against high-fat diet-induced hyperlipidaemia, indicating that they could be used as functional foods and natural hepatoprotectants.
format Online
Article
Text
id pubmed-5557422
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55574222017-08-16 Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 Zhang, Chen Li, Juan Wang, Jing Song, Xingling Zhang, Jianjun Wu, Shang Hu, Chunlong Gong, Zhiyuan Jia, Le BMC Complement Altern Med Research Article BACKGROUND: Hyperlipidaemia is the major risk factor contributing to the development and progression of atherosclerosis, fatty liver and cerebrovascular disease. Pleurotus eryngii (P. eryngii) is rich in biologically active components, especially polysaccharides that exhibit various biological activities, including reducing blood lipids. In the present study, three novel polysaccharide types, including exopolysaccharides (EPS), enzymatic EPS (EEPS) and acidic EPS (AEPS) were isolated, and the hypolipidaemic and hepatoprotective effects were investigated to better understand possible hypolipidaemic mechanisms and their hepatoprotective effects. METHODS: The EPS was hydrolysed by snailase (dissolved in 1% acetic acid, pH = 6) and H(2)SO(4) (1 M) to obtain EEPS and AEPS, respectively. The in vitro antioxidant activities were measured by investigating the reducing power and the scavenging effects on radicals of hydroxyl, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and superoxide anion. The hyperlipidaemic mice were induced by perfusing a high-fat emulsion. In addition to the hepatic histopathology, the following biochemical analyses were performed to investigate the antioxidative effects, including the activities of alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT). Triacylglycerol (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA) and lipid peroxidation (LPO) levels were also measured in serum and liver homogenate. RESULTS: Supplementation of EPS, EEPS and AEPS could significantly improve blood lipid levels (TC, TG, HDL-C, and LDL-C), hepatic lipid levels (TC and TG), hepatic enzyme activities (ALP, ALT, and AST) and antioxidant status (GSH-Px, SOD, T-AOC, MDA, and LPO). In addition, histopathological observations indicated that these polysaccharides had potential effects in attenuating hepatocyte damage. CONCLUSION: These results demonstrated that both EPS and its hydrolysates EEPS and AEPS might effectively reduce serum lipid levels and protect against high-fat diet-induced hyperlipidaemia, indicating that they could be used as functional foods and natural hepatoprotectants. BioMed Central 2017-08-14 /pmc/articles/PMC5557422/ /pubmed/28806986 http://dx.doi.org/10.1186/s12906-017-1892-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Chen
Li, Juan
Wang, Jing
Song, Xingling
Zhang, Jianjun
Wu, Shang
Hu, Chunlong
Gong, Zhiyuan
Jia, Le
Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
title Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
title_full Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
title_fullStr Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
title_full_unstemmed Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
title_short Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
title_sort antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from pleurotus eryngii si-04
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557422/
https://www.ncbi.nlm.nih.gov/pubmed/28806986
http://dx.doi.org/10.1186/s12906-017-1892-z
work_keys_str_mv AT zhangchen antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT lijuan antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT wangjing antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT songxingling antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT zhangjianjun antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT wushang antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT huchunlong antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT gongzhiyuan antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04
AT jiale antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04